compound
Retatrutide (6mg Vial) Questions Answered
Retatrutide is a novel triple agonist targeting GLP-1, GIP, and glucagon receptors [1] , studied for substantial weight loss and metabolic improvement in obesity and type 2 diabetes [2] [3] .
Retatrutide (6mg Vial)
Reconstitute: Add 1.2 mL bacteriostatic water → 5 mg/mL concentration. Typical weekly range: 2–12 mg once weekly (gradual escalation over 12+ weeks).
Retatrutide is a novel triple agonist targeting GLP-1, GIP, and glucagon receptors [1] , studied for substantial weight loss and metabolic improvement in obesity and type 2 diabetes [2] [3] .
Reconstitute: Add 1.2 mL bacteriostatic water → 5 mg/mL concentration. Typical weekly range: 2–12 mg once weekly (gradual escalation over 12+ weeks).
Plan based on a 12–48 week weekly protocol with gradual titration to maintenance dose.